Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of ciclesonide nasal spray for perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED